SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-040482
Filing Date
2022-02-14
Accepted
2022-02-14 11:39:53
Documents
2
Group Members
ALPHABET HOLDINGS LLCALPHABET INC.GV 2017 GP, L.L.C.GV 2017 GP, L.P.GV 2019 GP, L.L.C.GV 2019 GP, L.P.GV 2019, L.P.XXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d250198dsc13g.htm SC 13G 198723
2 EXHIBIT A d250198dex99a.htm EX-99.A 12803
  Complete submission text file 0001193125-22-040482.txt   213241
Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2017, L.P. (Filed by) CIK: 0001733340 (see all company filings)

IRS No.: 352587854 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Subject) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92700 | Film No.: 22627470
SIC: 2836 Biological Products, (No Diagnostic Substances)